Pathophysiology of primary hyperparathyroidism.
Primary hyperparathyroidism (PHPT) is characterized by hypersecretion of parathyroid hormone (PTH) leading to hypercalcemia and relative hypophosphatemia. PTH acts by binding to cell surface receptors coupled to G proteins. Cyclic AMP is the classic second messenger of PTH action, but substantial evidence indicates that PTH also acts to stimulate formation of the dual second messengers, inositol trisphosphate and diacylglycerol, thereby mobilizing intracellular calcium. The physiologic actions of PTH include (1) an increase in extracellular fluid ionized calcium through direct actions on kidney and bone, the classic target organs for PTH, and (2) a decrease in extracellular fluid phosphate primarily through renal action. The pathophysiologic effects of PTH arise from (1) direct actions of PTH on bone and kidney, and possibly on nonclassic target organs, and (2) indirect effects of altered mineral homeostasis. PTH hypersecretion in PHPT can lead to bony demineralization, nephrolithiasis, and hypercalcemic crisis. PHPT may also be associated with mental disturbances, neuromuscular disease, hypertension, and glucose intolerance.
Spiegel
A M
AM
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
D001665:Binding Sites; D002118:Calcium / Q000378:metabolism*; D019204:GTP-Binding Proteins / Q000737:chemistry; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D006961:Hyperparathyroidism / Q000150:complications / Q000503:physiopathology*; D007295:Inositol Phosphates / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism*; D010710:Phosphates / Q000097:blood; D015290:Second Messenger Systems
D007295:Inositol Phosphates; D010281:Parathyroid Hormone; D010710:Phosphates; D019204:GTP-Binding Proteins; D002118:Calcium